RC
ELV icon

Roundview Capital’s Elevance Health ELV Stock Holding History

Roundview Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-915
Closed -$338K – 327
2024
Q4 		$338K Sell
915
-1,253
-58% -$524K 0.02% 293
2024
Q3 		$1.13M Buy
2,168
+7
+0.3% +$3.74K 0.08% 209
2024
Q2 		$1.17M Buy
2,161
+44
+2% +$23.3K 0.09% 188
2024
Q1 		$1.1M Buy
2,117
+36
+2% +$17.9K 0.09% 201
2023
Q4 		$981K Hold
2,081
– – 0.09% 200
2023
Q3 		$906K Buy
2,081
+18
+0.9% +$8.16K 0.09% 201
2023
Q2 		$916K Buy
2,063
+147
+8% +$67.8K 0.09% 200
2023
Q1 		$881K Buy
1,916
+23
+1% +$10.9K 0.09% 199
2022
Q4 		$971K Hold
1,893
– – 0.11% 185
2022
Q3 		$860K Hold
1,893
– – 0.11% 172
2022
Q2 		$913K Buy
1,893
+35
+2% +$17.3K 0.11% 173
2022
Q1 		$912K Buy
1,858
+52
+3% +$23.8K 0.09% 184
2021
Q4 		$837K Sell
1,806
-131
-7% -$55.1K 0.08% 203
2021
Q3 		$722K Buy
+1,937
New +$736K 0.08% 211

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Roundview Capital's ELV Position: Q1 2025 in Review

Roundview Capital sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 915 shares — an estimated $338K sold.

Roundview Capital first reported a position in ELV in Q3 2021 and held it in 14 quarters. The position peaked at $1.17M in Q2 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Roundview Capital reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Roundview Capital sold 915 Elevance Health shares in Q1 2025, an estimated $338K.
  • Roundview Capital first reported a position in Elevance Health in Q3 2021 and held it in 14 quarters.
  • Roundview Capital's Elevance Health position peaked at $1.17M in Q2 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Roundview Capital's 13F filing for Q1 2025, filed 6 May 2025.